Joana Neves

4PUBLICATIONS
85CO-AUTHORS
Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

|Jun 12, 2026
SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy.

|Feb 28, 2024
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types.

Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang

|Jun 10, 2023
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.

Joana Jorge, Joana Neves, Raquel Alves

Pageof 1

Frequent Collaborators

3 joint publications

Helen M R Robinson

3 joint publications

Marco Ranzani

3 joint publications

Graeme C M Smith

3 joint publications

Jayesh Majithiya